Plasma physostigmine concentrations after controlled-release oral administration.
Thal
L J
LJ
Lasker
B
B
Sharpless
N S
NS
Bobotas
G
G
Schor
J M
JM
Nigalye
A
A
D000284:Administration, Oral; D000544:Alzheimer Disease / Q000188:drug therapy; D003692:Delayed-Action Preparations; D006801:Humans; D008297:Male; D010830:Physostigmine / Q000008:administration & dosage / Q000097:blood*
D003692:Delayed-Action Preparations; D010830:Physostigmine